METHOD FOR DIAGNOSING METABOLIC DISORDER

NOVEL BIOMARKER FOR DETERMINING DISEASE ACTIVITY OR PROGNOSIS OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

DIAGNOSIS OF IMMUNE-MEDIATED INFLAMMATORY DISEASES USING MMP12 AS INDICATOR, AND MEDICINE FOR TREATING IMMUNE-MEDIATED INFLAMMATORY DISEASES VIA MMP12 INHIBITION

REPORTER CELLS EXPRESSING CHIMERIC POLYPEPTIDES FOR USE IN DETERMINING PRESENCE AND OR ACTIVITY OF RECEPTORS ASSOCIATED WITH CANCER AND SELECTING TREATMENT

BIOSENSOR SYSTEM FOR DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER(FMF) DISEASE

PARTICLE FOR IMMUNOAGGLUTINATION ASSAY AND TEST REAGENT FOR IN VITRO DIAGNOSIS

PHARMACOLOGICAL INHIBITION OF MEK CAN IMPROVE OUTCOMES OF HYPERTROPHIC CARDIOMYOPATHY (HCM) IN INDIVIDUALS WITH NOONAN SYNDROME WITH MULTIPLE LENTIGINES (NSML)

DETECTION OF MEDICAL CONDITION, SEVERITY, RISK, AND ACUITY USING PARAMETERS

TRANSTHYRETIN BIOMARKERS FOR DETECTING AND MONITORING CANCERS

PHARMACOKINETIC MODELING SYSTEMS FOR IMPROVED THERAPEUTIC DOSING

PROTEIN BIOMARKERS FOR USE IN LUPUS NEPHRITIS

COLORIMETRIC DETECTION OF A VIRAL INFECTION

ANTI-CLDN6 ANTIBODIES AND USE THEREOF

CD11B AGONISTS FOR TREATMENT OF AUTOIMMUNE DISEASE

ANTI-sCD146 ANTIBODIES AND USES THEREOF

PRODUCTION AND USE OF NATURAL KILLER (NK) CELL-DERIVED EXTRACELLULAR VESICLES FOR TREATMENT OF CANCER AND INFECTIOUS DISEASE

LABELING AND DETECTION OF ASC SPECKS

Mass Spectrometry Kit Including a Cross-linked Antibody or Fragment Thereof

Biomarkers for Long COVID

Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients

FISH ALLERGY ANTIGEN

METHODS FOR SELECTING CULTURED CORNEAL ENDOTHELIAL CELLS

PLASMA THERMOGRAMS FOR DIAGNOSIS AND TREATMENT OF ACUTE MYOCARDIAL INFARCTION

METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY

COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 SPECIFIC ANTIBODIES

METHODS FOR QUANTIFYING FRATAXIN ACTIVITY

COMPOSITIONS, DEVICES, AND METHODS OF PSORIASIS FOOD SENSITIVITY TESTING

ASSAYS FOR LYSOSOMAL STORAGE DISEASES

Vaccines and Antibodies for the Treatment and Prevention of Neurodegenerative Disorders and Inflammation Related Health Conditions

COMPOSITIONS AND METHODS FOR MARCO INHIBITION AND IMPROVED DRUG DELIVERY

COMPOSITIONS AND METHODS UTILIZING A NOVEL HUMAN FOXO3 ISOFORM

METHODS AND SYSTEMS FOR RAPID DETECTION OF STROKE AND DETERMINATION OF ONSET VIA NEUROINFLAMMATION BIOMARKERS

BIOMARKERS IN LONG-COVID-19

INFLAMMATORY DISEASE GENE PANEL

SYSTEMS AND METHODS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA BASED ON THE DETECTION AND INTERPRETATION OF A PANEL OF MICRORNAS IN A SUBJECT

DESMIN TYROSINE PHOSPHORYLATED MUTANT AND PANCREATIC CANCER

METHOD FOR TREATING SEPSIS AND RELATED DISEASES

Use Of P55gamma As Therapeutic Target For Aortic Dissection (ad)

SAPOSIN-A DERIVED PEPTIDES AND USES THEREOF

Method of Determining Risk for Chronic Stress and Stroke

BIOMARKER FOR MYASTHENIA GRAVIS

NEUROENDOCRINE CARCINOMA DETECTION AND TREATMENT

METHODS FOR DETECTING FRACTURE-RELATED INFECTION (FRI)

NOVEL POINT OF CARE SYSTEM AND METHOD USED FOR THE SAME

METHODS FOR AIDING IN DIAGNOSING AND EVALUATING A TRAUMATIC BRAIN INJURY IN A HUMAN SUBJECT USING A COMBINATION OF GFAP AND UCH-L1

PREVENTION AND TREATMENT OF CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY ASSOCIATED WITH CAR-T CELL THERAPY

COMPOSITIONS, DEVICES, AND METHODS OF OSTEOARTHRITIS SENSITIVITY TESTING

BIOMARKER COMPOSITIONS, PROTEIN PANELS, DEVICES, AND METHODS TO IDENTIFY RISK OF AND TREAT PULMONARY VASCULAR INADEQUACY IN SINGLE VENTRICLE HEART DISEASE

Proteomic Risk Score For Adjudicated Arthropathy (AA)

BIOMARKERS FOR DETECTING AND MONITORING BREAST CANCER

METHOD OF TREATMENT OF HIV INFECTION WITH VACCINE

DIAGNOSING AND TREATING END-STAGE RENAL DISEASE (ESRD) IN OBESE SUBJECTS

EXTRACELLULAR VESICLES-BASED BIOMARKERS FOR PANCREATIC CANCER

METHOD FOR MEASURING MINERALOCORTICOID RECEPTOR ACTIVITY

BIOMARKERS FOR CHRONIC FATIGUE SYNDROME AND LONG COVID AND USES THEREOF

METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST

METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS

PROTEIN MARKER PANEL FOR SCREENING CLINICAL FUTILE RECANALIZATION (FR) IN LARGE VESSEL OCCLUSION-INDUCED ACUTE ISCHEMIC STROKE (LVO-AIS) AND USE THEREOF

USE OF CEREBROSPINAL FLUID-DERIVED ANTI-VIMENTIN IGG AS MARKER IN DIAGNOSIS OF VIMENTIN ANTIBODY-ASSOCIATED ASTROCYTOPATHY

METHODS FOR DETECTING B-ISOX PRECIPITATES OR CAPTURED PROTEINS AS BIOFLUID BIOMARKERS FOR DIFFERENTIAL DIAGNOSTIC, PATHOPHYSIOLOGY MONITORING OR PRESYMPTOMATIC DIAGNOSTIC OF PREDIABETES, DIABETES AND CANCERS

MULTI-PROTEIN BIOMARKER ASSAY FOR BRAIN INJURY DETECTION AND OUTCOME

Chronic kidney disease detection

METHODS FOR LARGE TISSUE LABELING, CLEARING AND IMAGING

PROTEASE-CLEAVABLE MOIETIES AND METHODS OF USE THEREOF

ANTI-AXL ANTIBODIES, ANTIGEN-BINDING FRAGMENTS THEREOF AND METHODS FOR MAKING AND USING THE SAME

ALPHAVIRUS T CELL EPITOPES, MEGAPOOLS AND USES THEREOF

IGFBP7 RATIO FOR HFpEF

LEUKOTRIENE A4 HYDROLASE (LTA4H) AS (BLOOD) BIOMARKER FOR THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME

COMPOSITIONS, DEVICES, AND METHODS OF FUNCTIONAL DYSPEPSIA SENSITIVITY TESTING

COMBINATION TREATMENT FOR CANCER

TREATMENT OF MHC-I NEGATIVE TUMORS WITH NK AND T CELLS

BIOMARKER FOR DIAGNOSING CENTRAL PRECOCIOUS PUBERTY IN FEMALES AND USES THEREOF

Discriminating Parkinson's Disease from Multiple System Atrophy Using Alpha- Synuclein PMCA

COMPOSITIONS AND METHODS FOR TREATING CANCER BY INHIBITING MITOCHONDRIAL STRESS-INDUCED PROTEIN CARBOXYL-TERMINAL ALANINE AND THREONINE TAILING (MSICAT-TAILING)

DETERMINATION OF PARKINSON'S DISEASE

PROGNOSTIC AND DIAGNOSTIC METHODS FOR RISK OF ACUTE KIDNEY INJURY

MARKERS FOR DIAGNOSING INFECTIONS

METHODS FOR DETECTING ANTI-PORCINE ANTIBODIES

PROLIFERATION ASSAY FOR FIXED SOLID TUMORS

METHODS FOR SELECTING MEDICATIONS FOR TREATING PATIENTS HAVING ATTENTION-DEFICIT HYPERACTIVITY DISORDER

PRECISION MEDICINE FOR PAIN: DIAGNOSTIC BIOMARKERS, PHARMACOGENOMICS, AND REPURPOSED DRUGS

COMP PEPTIDE AND ANTIBODIES THERETO FOR DIAGNOSING OSTEOARTHRITIS

COMPLEMENT C4D ASSAY

METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY

Use Of Serine/Arginine-Rich Splicing Factor 1 (SRSF1) As Therapeutic Target For Aortic Dissection

METHODS OF TREATING MALIGNANT GLIOMAS

METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS

CIRCULATING PROTEIN BIOMARKERS OF NECROTIZING ENTERROCOLITIS

METEORIN-LIKE PROTEIN (METRNL) AS (BLOOD) BIOMARKER FOR THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME

COMPOSITIONS, DEVICES, AND METHODS OF GASTROESOPHAGEAL REFLUX DISEASE SENSITIVITY TESTING

COMPOSITIONS, DEVICES, AND METHODS OF ECZEMA FOOD SENSITIVITY TESTING

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROPHYLAXIS AND TREATMENT OF LYME DISEASE

ANTIBODIES THAT BIND TO NATIVELY FOLDED MYOCILIN

ORGAN AGING BIOMARKERS DERIVED FROM THE PLASMA PROTEOME

BIOMARKERS

BIOMARKERS FOR FIBROSIS TREATMENT USING ANTI-CLAUDIN-1 ANTIBODIES

EXPERIMENTAL METHOD FOR CLINICAL RESEARCH OF TARGETING MOLECULES BASED ON ATRIAL FIBRILLATION WARNING SYSTEM

METHODS OF TREATING, AMELIORATING AND/OR PREVENTING WOUNDS

BIOMARKERS OF FIBROSIS AND USES THEREFOR

BIOMARKER AND DRUG COMBINATIONS FOR HEART FAILURE PREDICTION

SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION

GENERATING A COMPOSITE RESULT USING INFLAMMATION DATA

Discriminating Parkinson's Disease from Multiple System Atrophy Using Alpha-Synuclein PMCA

MARKERS FOR RENAL DISEASE

METHODS FOR ASSESSING MUCOSAL HEALING IN INFLAMMATORY BOWEL DISEASE PATIENTS

COMPOSITIONS AND METHODS FOR DETECTION OF METASTASIS

ANTIBODIES THAT BIND TO IGE-DEPENDENT HISTAMINE-RELEASING FACTOR AND USES THEREOF

MASS SPECTROMETRIC ANALYSIS OF BIOMARKERS

METHODS AND DEVICES FOR QUANTITATIVELY ESTIMATING THROMBOMODULIN

TARGETING S100A9-ALDH1A1-RETINOIC ACID SIGNALING TO SUPPRESS BRAIN RELAPSE IN EGFR-MUTANT LUNG CANCER

ASSESSMENT OF CHRONIC LIVER DISEASE

METHODS INVOLVING DETECTING TNF STIMULATED GENE 6 (TSG-6) FOR IMPROVING ANTI-TUMOR RESPONSES TO IMMUNE THERAPY IN CANCER PATIENTS

METHODS RELATING TO DIAGNOSING STABILITY FOLLOWING RENAL TRANSPLANTATION

Siglec Receptor Checkpoint Inhibitors and Method of Using Them to Inhibit Neoplastic Cell Growth

CD146 AND USES THEREOF AS A BIOMARKER AND AS A THERAPEUTIC TARGET IN THE DIAGNOSIS AND TREATMENT OF FIBROSIS

PRESCRIPTION OF REMOTE PATIENT MANAGEMENT BASED ON BIOMARKERS

APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS

METHOD FOR DETERMINING THE THERAPEUTIC REGIMEN FOR AN INDIVIDUAL AND ITS USE

METHODS OF DETECTING DDR1 PHOSPHORYLATION

PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCS) FOR DIAGNOSTIC TESTING

STRUCTURE-BASED PROBE FOR DETECTION OF TRANSTHYRETIN AMYLOID FIBRILS AND AGGREGATES

BIOMARKERS AND USE THEREOF FOR DIAGNOSIS, PREVENTION, AND TREATMENT OF MUSCLE ATROPHY

METHODS FOR TREATING CHOLESTASIS

URINARY BRANCHED-CHAIN AMINO ACIDS (UBCAAS) AS INSULIN RESISTANCE BIOMARKERS

BIOMARKERS OF LYSOSOMAL STORAGE DISEASE

METHODS RELATING TO RESPIRATORY HEALTH THERAPEUTICS

SERINE PROTEASE INHIBITOR KAZAL (SPIK) COMPOSITIONS AND METHODS

NANOLIPOSOME COMPOSITIONS AND METHODS OF USING THE SAME

ADJUSTED MULTI-BIOMARKER DISEASE ACTIVITY SCORE FOR INFLAMMATORY DISEASE ASSESSMENT

METHOD FOR TESTING FOR KIDNEY DISEASES

METHODS FOR MONITORING MOLECULAR BIOMARKERS FOR AGING AND DISEASE

METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS

BIOLOGICAL MARKERS OF LIVER FAT

ANTI-BDCA2 ANTIBODY AND USE THEREOF

ANTI-FCRN ANTIBODIES

METHODS FOR DETECTING OR TREATING ATHEROSCLEROSIS

METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF RENAL DISEASE AND PERIODONTAL DISEASE

USE OF ANTI-CITRULLINATED PEPTIDE ANTIBODY AS BIOMARKER FOR DIAGNOSIS AND PROGNOSIS OF AORTIC VALVE STENOSIS

SYSTEM FOR DETECTING INFECTION IN SYNOVIAL FLUID

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE

ASSESSMENT OF INTESTINAL BARRIER FUNCTION TO IMPROVE TREATMENT OF INFLAMMATORY BOWEL DISEASE

CU GROWTH ENHANCED PLASMONIC ASSAY FOR ISOLATION-FREE EXOSOME ANALYSIS

TREATING TUBEROUS SCLEROSIS COMPLEX-ASSOCIATED DISEASES

MARKER FOR CANCER DETECTION (BC / or BF9)

WORKFLOWS FOR DISCOVERY AND DEPLOYMENT OF DIAGNOSTIC ASSAYS COMBINING PROTEOMIC AND GENOMIC INFORMATION

SULCUS-PROTEINS FOR THE DETECTION OF PERI-IMPLANTITIS

SYSTEM AND METHODS FOR DIAGNOSING ACUTE INTERSTITIAL NEPHRITIS

METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE LAUNDRY MALODOR, MOLDY MALODOR, OR SWEAT MALODOR

Methods for Targeting Cancer Cells Using Amino Acids

METHODS RELATING TO IMPAIRED RESPIRATORY HEALTH THERAPEUTICS

COMPOSITIONS AND METHODS TO DETECT INFECTIOUS ORGANISMS

METHODS FOR TREATING ACUTE KIDNEY INJURY

NOVEL ANTI-PD-L1 ANTIBODIES

HUMAN UMBILICAL CORD BLOOD FOR USE IN ALLEVIATING FATIGUE

METHODS AND KITS FOR DETECTION OF AMYLIN-BETA AMYLOID CO-AGGREGATION

BIOMARKER COMPOSITION FOR EARLY DIAGNOSIS OF KIDNEY DISEASES, AND METHOD FOR PROVIDING INFORMATION REQUIRED FOR EARLY DIAGNOSIS OF KIDNEY DISEASES BY USING SAME

METHODS FOR PREDICTING TREATMENT RESPONSE IN PSORIASIS

Detection of Liver Disease

INDIVIDUALIZED LIFESTYLE INTERVENTION FOR OBESITY MANAGEMENT BASED ON OBESITY PHENOTYPES

Methods for Prognosing Type 1 Diabetes Treatments

ANTI-GDF15 ANTIBODY USED IN A COMBINATION TREATMENT OF SPECIFIC PATIENT GROUPS AND A DOSAGE REGIMEN FOR THE TREATMENT OF CANCER

NOVEL USE OF ANTICANCER AGENT PRODRUG CONJUGATE

PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CYSTIC DISEASE

Use of reagent for detecting C1QBP protein expression level in preparation for oral cancer screening or prognosis kit

METHODS AND COMPOSITIONS FOR ASSESSING AND TREATING PERSISTENT ACUTE KIDNEY INJURY BASED ON C-C MOTIF CHEMOKINE LIGAND 14 MEASUREMENT

METHODS FOR NONINVASIVE MONITORING OF BRONCHOPULMONARY DYSPLASIA

METHODS AND KITS FOR QUANTIFYING GLYCOSYLATED ANALYTES

METHODS AND COMPOSITIONS FOR PROGNOSIS AND TREATMENT OF DILATED CARDIOMYOPATHY AND HEART FAILURE

Novel Treatment of Diabetes and Kidney Disease by Inhibition of D2D3 a Proteolytic UPAR

METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING LOSS AND/OR DISTORTION OF TASTE OR SMELL

ANTIBODIES

PHARMACEUTICAL COMPOSITION COMPRISING CDON-IG2 DOMAIN PROTEIN FOR TREATING VASCULAR CALCIFICATION

PROBES AND METHODS FOR TARGETED VISUALIZATION OF NLRP3 INFLAMMASOMES

METHODS FOR PREDICTING AND TREATING CHRONIC LUNG ALLOGRAFT DYSFUNCTION

PTX3 BIOMARKER FOR REDUCING ANTIBIOTIC TREATMENT IN NEWBORNS

METHOD FOR THE PROGNOSIS OF PATIENTS SUFFERING FROM ATRIAL FIBRILLATION

PREVENTION OF DIABETES BY ENHANCEMENT OF IMMUNE MODULATION

METHOD FOR PREDICTING ATOPIC DERMATITIS RELAPSE

MONOCLONAL ANTIBODY-BASED BIOSENSOR FOR POINT-OF-CARE DETECTION OF TYPE III SECRETION SYSTEM EXPRESSING PATHOGENS

NOVEL METHOD FOR DETERMINING A CONCENTRATION OF N-TERMINAL PRO-HORMONE BNP (NT-PROBNP) IN A SAMPLE

BIGLYCAN PEPTIDE AND ANTIBODIES

USE OF MATURE MITOCHONDRIAL TRANSCRIPTION FACTOR A (TFAM) FOR DIAGNOSING ORGAN DYSFUNCTIONS

METHODS OF DETECTING AMINO ACID DEFICIENCIES

CLDN18.2 ANTIBODY AND USE THEREOF

MICROFLUIDIC URINE ALBUMIN/CREATININE CHIP (uACR-CHIP) FOR CHRONIC KIDNEY DISEASE EVALUATION

IDENTIFICATION OF PROTHROMBOTIC CONDITIONS

METHODS FOR PREDICTION AND EARLY DETECTION OF DIABETES

ASSAY METHODS, ASSAY CARTRIDGES, AND ASSAY DEVICES INCLUDING MAGNETIC PARTICLE DE-AGGREGATION

METHODS FOR IMPROVING OUTCOMES FOR HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS AT RISK FOR BRONCHIOLITIS OBLITERANS SYNDROME

METHODS OF DETECTING AND TREATING GYNECOLOGICAL DISEASES

ANTIBODY AGAINST KYNURENINE

HRG MEASURING METHOD USING ANTI-HRG MONOCLONAL ANTIBODIES

MICROENVIRONMENTAL DETERMINANTS OF CLONAL HEMATOPOIESIS EXPANSION RATE

METHODS FOR PREDICTING THE RISK OF DEVELOPING MULTISYSTEM INFLAMMATORY SYNDROME (MIS) FOLLOWING EXPOSURE TO AN INFECTIOUS AGENT AND FOR DIAGNOSING MIS FOLLOWING EXPOSURE TO AN INFECTIOUS AGENT

Proteins and T-Cells Involved in Chronic Inflammatory Diseases

USE OF MMP19 AS BIOMARKER RELATED TO EARLY KIDNEY INJURY IN EARLY DIAGNOSIS OF KIDNEY INJURY

COMPOSITIONS AND METHODS FOR NEURALGENESIS

Cancer Treatment

METHOD OF USING TEMPORAL ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY AND MACHINE LEARNING FOR BIOSENSING

BIOMARKERS FOR IDIOPATHIC PULMONARY FIBROSIS AND METHODS OF PRODUCING AND USING SAME

APOB:CFAS CONTENT TO AID IN THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES

METHODS FOR THE DETECTION AND TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA

Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis

DIAGNOSING AND TREATING A PATHOLOGICAL CONDITION OF THE INTESTINAL TRACT

ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF II

IMPROVED DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS

ANTI-C3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF AND THEIR USES FOR TREATING EYE OR OCULAR DISEASES

TARGETED DEFA5 ANTIBODY AND ASSAY METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE

BIOMARKERS FOR OVARIAN CANCER

CMYBPC MARKER COMBINATIONS FOR EARLY DISCRIMINATION OF TYPE 2 VERSUS TYPE 1 ACUTE MYOCARDIAL INFARCTION

METHOD FOR PREDICTING THE POSTOPERATIVE RISK OF BRAIN-INJURED PATIENTS AND THE USE OF STEROIDS/PROTEINS FOR PREDICTING THE POSTOPERATIVE RISK OF BRAIN-INJURED PATIENTS

METHOD FOR THE EARLY DIAGNOSIS OF GLAUCOMA

Methods for Sample Quality Assessment

BIOMARKER IDENTIFICATION FOR IMMINENT AND/OR IMPENDING HEART FAILURE

USE OF TREM-1 FOR PREDICTING AND PREVENTING POSTOPERATIVE COMPLICATIONS AFTER CARDIAC SURGERY WITH CARDIOPULMONARY BY-PASS

USE OF FSH-RECEPTOR LIGANDS FOR DIAGNOSIS AND THERAPY OF ATHEROSCLEROSIS

METHODS FOR THE DIAGNOSIS AND TREATMENT OF T-CELL MALIGNANCIES

METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY

MARKERS FOR PROGRESSION OF INFLAMMATORY LIVER DISEASE

IMMUNE CELL SELECTION, EXPANSION, AND USE

SYSTEMS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC ORGAN REJECTION

BIOMARKERS FOR PREDICTING TYPE 2 DIABETES STATUS

ALPHA-1 ANTITRYPSIN Z- AND M-SPECIFIC BINDING PROTEINS

PAPER-BASED MICROFLUIDIC CHIP FOR MEASUREMENT OF CYSTATIN C IN PLASMA AND SERUM (CYS-C PAPER CHIP)

ASSAY FOR LONG FORMS OF CARDIAC TROPONIN T

SENESCENT CELL SURFACE MARKERS

IN SITU DETECTION OF COPY NUMBER VARIATIONS IN BIOLOGICAL SAMPLES

METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE

CONSTRUCTS, VIRAL VECTORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING LONG NONCODING RNA ANRIL FOR TREATMENT OF DISEASE

Determining A Cardiovascular Ischemic Event And Decision Support Tool

METHOD FOR PREDICTING PROGNOSTIC INDICATIONS OF PANCREATIC CANCER PATIENTS

USE OF COMBINED CD274 COPY NUMBER CHANGES AND TMB TO PREDICT RESPONSE TO IMMUNOTHERAPIES

CYCLIN-DEPENDENT KINASE 2 INHIBITORS FOR MEDICAL TREATMENT

METABOLITE BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM

METHODS FOR DETECTING CM-TMA BIOMARKERS

METHODS OF EVALUATING TREATMENT OUTCOME IN HIGH GRADE SEROUS OVARIAN CANCER

ANALYTICAL METHOD AND THERAPEUTICAL AGENT FOR USE IN COMBINATION WITH L-ASPARAGINASE IN TUMOUR THERAPY

NOVEL BIOMARKER VISTA FOR DIAGNOSIS AND PROGNOSIS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

SAMPLE INCLUDING PRO-ADM AS A THERAPY MONITORING MARKER FOR CRITCALLY ILL PATIENTS

SAMPLE PREPARATION FOR GLYCOPROTEOMIC ANALYSIS THAT INCLUDES DIAGNOSIS OF DISEASE

METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

Compositions and Methods for Diagnosing and Treating Intellectual Disabilities

METHODS FOR AIDING IN DIAGNOSING AND EVALUATING A MILD TRAUMATIC BRAIN INJURY IN A HUMAN SUBJECT USING CARDIAC TROPONIN I

METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS BIOMARKER COMPOSITIONS AND APPLICATIONS THEREOF

COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING PSYCHIATRIC ILLNESS

METHOD FOR DIAGNOSING ACUTE EXACERBATION OF BRONCHIECTASIS AND KIT THEREFOR

IL-18 BINDING PROTEIN (IL-18BP) IN THE TREATMENT OF VEXAS

Predicting Recurrent Urolithiasis And Decision Support Tool

NONINVASIVE METHOD TO QUANTIFY KIDNEY FUNCTION AND FUNCTIONAL DECLINE

Biosignatures for Fatigue Syndromes

PEPTIDE QUANTITATION ASSAY FOR DIFFERENTIATING FULL-LENGTH HIGH MOLECULAR WEIGHT KININOGEN (HMWK) AND CLEAVED HMWK

BIOMARKERS AND METHODS FOR ASSESSING PSORIATIC ARTHRITIS DISEASE ACTIVITY

METHOD OF TREATING CANCER USING WRS INHIBITORS

SENOTHERAPEUTIC AGENTS AND ALPHA-KLOTHO POLYPEPTIDES

USE OF GAMMA PRIME FIBRINOGEN AS A BIOMARKER IN THE ASSESSMENT OF COVID-19 INFECTIONS AND PROGNOSIS OF SEVERE DISEASE

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CARDIOMYOPATHY IN A FELINE

SENSING DEVICE FOR PREDICTING THE RISK OF AN COPD AND/OR ASTHMA ATTACK, MEASUREMENT ARRANGEMENT AND METHOD FOR THE MAINTENANCE OF THE SENSING DEVICE

DETECTION OF EXTRACELLULAR VESICLE BIOMARKERS FOR THE DIAGNOSIS OF AUTISM SPECTRUM DISORDER

IDENTIFICATION AND MEDICAL APPLICATIONS OF ANTI-CITRULLINATED-PROTEIN ANTIBODIES IN RHEUMATOID ARTHRITIS

USE OF MICROVESICLE SIGNATURES IN THE IDENTIFICATION AND TREATMENT OF RENAL DISORDERS

ANTI-TRANSTHYRETIN (TTR) BINDING PROTEINS AND USES THEREOF

TUMOR MHC CLASS I EXPRESSION IS ASSOCIATED WITH INTERLEUKIN-2 RESPONSE IN MELANOMA

METHODS AND COMPOSITIONS FOR THE CONTROL OF INFLAMMATION IN SKIN DISEASE

TREATMENT OF CIRCADIAN RHYTHM DISORDERS

STRESS TEST AND TREATMENT OF CHRONIC KIDNEY DISEASE

Predicting Recurrent Urolithiasis And Decision Support Tool

Predicting Recurrent Urolithiasis And Decision Support Tool

MONITORING INFLAMMATION STATUS

Determining A Cardiovascular Ischemic Event And Decision Support Tool

Determining A Cardiovascular Ischemic Event And Decision Support Tool

METHOD OF DETECTING TISSUE DAMAGE

Method for detecting and subtyping inflammatory intestinal diseases

USE OF SET7/9 FOR DIAGNOSING AND TREATING ENDMT-RELATED DISEASE

GLYCAN STRUCTURES OF HAPTOGLOBIN AS A BIOMARKER OF HEPATOCELLULAR CARCINOMA

DIAGNOSIS OF COLORECTAL CANCER USING TARGETED QUANTIFICATION OF SITE-SPECIFIC PROTEIN GLYCOSYLATION

METHODS OF DIAGNOSTIC SCREENING AND EARLY DETECTION OF ADENOMYOSIS

Methods and Applications of Analyzing the Perfusate of an Ex Situ Perfused Kidney

NEW METHOD FOR IDENTIFYING HERV-DERIVED EPITOPES

AUTOANTIBODIES AGAINST NaV1.5 CHANNEL AS BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME AND RELATED THERAPEUTIC METHODS

RECOMBINANT ANTIBODY OF ANTI-HUMAN CARDIAC TROPONIN I

METHODS FOR IMPROVING LUNG TRANSPLANTS

METHODS FOR THE DETECTION AND TREATMENT OF OVARIAN CANCER

ACTIVATED RAS AS THERAPEUTIC AND DIAGNOSTIC TARGET FOR NEUROFIBROMATOSIS AND USE THEREOF

METHODS FOR IMPROVING THE EFFICACY OF HDAC INHIBITOR THERAPY AND PREDICTING THE RESPONSE TO TREATMENT WITH HDAC INHIBITOR

NEWBORN SCREENING FOR PRIMARY IMMUNODEFICIENCIES, CYSTINOSIS, AND WILSON DISEASE

METHOD FOR DIAGNOSING ENDOMETRIOSIS AND FOR CLASSIFYING THE STAGE OF ENDOMETRIOSIS

METHODS AND MATERIALS FOR IDENTIFYING AND TREATING VACCINE-INDUCED IMMUNE THROMBOTIC THROMBOCYTOPENIA

IDENTIFICATION OF COMMON TUMOR-SPECIFIC T CELL RECEPTORS AND ANTIGENS

METHOD OF IDENTIFYING AGENTS FOR THE TREATMENT OF CYSTIC FIBROSIS CAUSED BY THE MUTATION F508DEL

TREATMENT OF VAGINAL DYSBIOTIC CONDITIONS WITH ASSOCIATED ELEVATED VAGINAL CALPROTECTIN

CANCER IMMUNOTHERAPY COMPOSITION CONTAINING INTERACTION INHIBITOR OF STING AND TRIM29 AS ACTIVE INGREDIENT

BIOMARKERS FOR EARLY DETECTION OF DIABETES

METHODS AND DEVICES FOR DETECTION OF ORTHOGONAL CLASSES OF DISEASE BIOMARKERS

METHOD FOR EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION

LG3 Assay

METHODS OF TREATING OR PREVENTING GRAFT VERSUS HOST DISEASE

ANTI-Ly6E ANTIBODIES, IMMUNOCONJUGATES, AND USES THEREOF

BIOMARKERS OF METHOTREXATE-INDUCED IMMUNE TOLERANCE

PHOSPHOPEPTIDE/PHOSPHOPROTEIN SIGNATURE PREDICTING BASAL-LIKE BREAST CANCER RECURRENCE